MedPath

ANNJI PHARMACEUTICAL CO., LTD.

ANNJI PHARMACEUTICAL CO., LTD. logo
๐Ÿ‡น๐Ÿ‡ผTaiwan
Ownership
Public
Established
2014-01-01
Employees
11
Market Cap
-
Website
http://www.ajpharm.com

Clinical Trials

3

Active:0
Completed:2

Trial Phases

1 Phases

Phase 1:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)โ€ข Click on a phase to view related trials

Phase 1
3 (100.0%)

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJ302-IM in Healthy Volunteers

Phase 1
Recruiting
Conditions
Healthy Volunteers
Interventions
Drug: Placebo
First Posted Date
2024-10-03
Last Posted Date
2024-10-03
Lead Sponsor
AnnJi Pharmaceutical Co., Ltd.
Target Recruit Count
56
Registration Number
NCT06625541
Locations
๐Ÿ‡บ๐Ÿ‡ธ

AnnJi Investigational Site, Miami, Florida, United States

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients

Phase 1
Completed
Conditions
Spinal and Bulbar Muscular Atrophy
Kennedy's Disease
Interventions
Drug: Placebo
First Posted Date
2022-08-26
Last Posted Date
2024-08-15
Lead Sponsor
AnnJi Pharmaceutical Co., Ltd.
Target Recruit Count
25
Registration Number
NCT05517603
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of California, Irvine, Orange, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Stanford University, Palo Alto, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Mayo Clinic, Rochester, Minnesota, United States

and more 2 locations

A Study to Investigate the Safety, Tolerability, Pharmacokinetics of ALZ002 DS in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: ALZ002 DS
Drug: Placebo
First Posted Date
2020-05-19
Last Posted Date
2021-08-18
Lead Sponsor
AnnJi Pharmaceutical Co., Ltd.
Target Recruit Count
72
Registration Number
NCT04392830
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

Cmax clinical research, Adelaide, Australia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.